Externalized attributional bias in the Ultra High Risk (UHR) for psychosis population

A Thompson; A Papas; C Bartholomeusz; B Nelson; A Yung

Journal article

Externalized attributional bias in the Ultra High Risk (UHR) for psychosis population

A Thompson, A Papas, C Bartholomeusz, B Nelson, A Yung

Psychiatry Research | ELSEVIER IRELAND LTD | Published : 2012

DOI: 10.1016/j.psychres.2012.10.017

Abstract

Specific externalizing attributional biases appear to be common in early psychosis. They may represent trait risk factors for the later development of a psychotic disorder, yet few studies have investigated this in clinical "at risk" populations. We aimed to investigate one particular bias, the Locus of Control of reinforcement (LOC) in a "Ultra High Risk" (UHR) for psychosis group. We recruited UHR individuals from an established at risk clinical service and a community control group. LOC was measured using the Adult Nowicki Strickland Internal External scale (ANSIE). Neuropsychological functioning, social functioning and psychopathology were assessed. We analyzed data from 30 controls and ..

View full abstract

University of Melbourne Researchers

Andrew Thompson Author

Cali Bartholomeusz Author

Barnaby Nelson Author

Related Projects (2)

EMERGING MENTAL DISORDERS IN YOUNG PEOPLE: USING CLINICAL STAGING FOR PREDICTION, PREVENTION AND EARLY INTERVENTION

Mental disorders are a major cause of disability in Australia, especially for young people. We have developed a clinical staging model cover..

EMERGING MENTAL DISORDERS IN YOUNG PEOPLE: USING CLINICAL STAGING FOR PREDICTION, PREVENTION AND EARLY INTERVENTION

Mental disorders are a major cause of disability in Australia, especially for young people. We have developed a clinical staging model cover..

Grants

Awarded by NHMRC

Funding Acknowledgements

[ "The study was partly funded by a Pfizer Neurosciences Investigator Grant. The funding source had no input into any aspect of the study.", "Dr Thompson has received unrestricted investigator-initiated trial funding from Janssen-Cilag and Astra-Zeneca. He also holds a Pfizer Neurosciences Research Grant which partly funded this study. Dr Nelson was supported by a Ronald Phillip Griffith Fellowship from the University of Melbourne and a NARSAD Young Investigator Award. Dr. Bartholomeusz is supported by a National Health and Medical Research Council (NHMRC) Clinical Postdoctoral Research Fellowships. Professor Yung currently receives research support from a NHMRC Senior Research Fellowship, a NHMRC Program Grant (no. 566529), and the Colonial Foundation." ]